Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.070
-0.050 (-4.46%)
At close: Dec 17, 2025, 4:00 PM EST
1.100
+0.030 (2.78%)
After-hours: Dec 17, 2025, 6:41 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $200.38 million as of December 17, 2025. Its market cap has decreased by -65.00% in one year.
Market Cap
200.38M
Enterprise Value
231.86M
1-Year Change
-65.00%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $200.38M, an increase of 61.20%. That is a compound annual growth rate of 9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 200.38M | -69.16% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |